Word

MAKING NANOPHARMACEUTICALS BIG

Status

Dead

Status Code

606

Status Date

Monday, September 29, 2014

Serial Number

85685717

Mark Type

4000

Filing Date

Tuesday, July 24, 2012

Published for Opposition

Tuesday, January 1, 2013

Abandoned Date

Monday, September 29, 2014

Trademark Owner History

Cerulean Pharma Inc. - Owner At Publication

Classifications

1 diagnostic and prognostic preparations for clinical or medical laboratory use; diagnostic and prognostic reagents for identifying a disease or disorder and/or the progression of a disease or disorder

5 Pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of oncological diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of pre-cancerous diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of benign and malignant cancers or neoplasms; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of inflammation and inflammatory diseases or disorders; pharmaceutical preparations for use in the diagnosis, prognosis, and treatment of cardiovascular diseases or disorders; pharmaceutical preparations for use in modulating angiogenesis; pharmaceutical preparations for use in chemotherapy; pharmaceutical preparations, namely, drug delivery systems that contain compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain nanometer scale or nanometer size compounds which facilitate the delivery of a wide range of pharmaceuticals; pharmaceutical preparations, namely, drug delivery systems that contain polymer and/or lipid based compounds for controlled release of a wide range of pharmaceuticals; pharmaceutical preparations for the treatment of oncological diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of pre-cancerous diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of benign and malignant cancers or neoplasms comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of inflammation and inflammatory diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical; pharmaceutical preparations for the treatment of cardiovascular diseases or disorders comprising a pharmaceutical included with a nanometer-sized composition which facilitates the delivery and/or the controlled release of the pharmaceutical

42 Medical and scientific research services, namely, research, development, analytical, formulation, and product development services in the pharmaceutical field

Trademark Events

Sep 29, 2014

Abandonment Notice Mailed - No Use Statement Filed

Sep 29, 2014

Abandonment - No Use Statement Filed

Mar 4, 2014

Notice Of Approval Of Extension Request Mailed

Mar 3, 2014

Extension 2 Granted

Feb 11, 2014

Extension 2 Filed

Mar 2, 2014

Case Assigned To Intent To Use Paralegal

Feb 11, 2014

Teas Extension Received

Mar 21, 2013

Notice Of Approval Of Extension Request Mailed

Mar 19, 2013

Extension 1 Granted

Mar 19, 2013

Extension 1 Filed

Mar 19, 2013

Teas Extension Received

Feb 26, 2013

Noa Mailed - Sou Required From Applicant

Jan 1, 2013

Published For Opposition

Dec 12, 2012

Notice Of Publication

Nov 27, 2012

Approved For Pub - Principal Register

Nov 19, 2012

Assigned To Examiner

Jul 31, 2012

New Application Office Supplied Data Entered In Tram

Jul 27, 2012

New Application Entered In Tram